This site uses cookies for analytics and to improve your experience. By clicking Accept, you consent to our use of cookies. Learn more in our privacy policy.

Subscribe
Watch

PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner

PharmAla Biotech provides a corporate update relating to its investment banking partner, Canaccord Genuity LLC, and its IP. Source: PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner

Globe News Wire Avatar

by

Globe News Wire
1 minute

Read Time

PharmAla Biotech provides a corporate update relating to its investment banking partner, Canaccord Genuity LLC, and its IP.

Source: PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner

Tags: , , ,

Previous Post

Next Post

Latest News

View All

About the Author

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

You May Have Missed

View All